CLINICAL_TRIALS trial_result · 2017-02-23

Clinical Trial Update: Add-on to Thiazolidinedione (TZD) Failures [Phase 3]

Phase 3 trial evaluating an add-on therapy to thiazolidinediones in Type 2 diabetes mellitus has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2017-02-23